Institution:
Dana-Farber Cancer Institute, Harvard Medical School & Howard Hughes Medical Institute
Discipline:
Molecular & Cellular Biology
Recognized for: Transformative work to discover and characterize chromatin remodeling complexes, understand how their disruption leads to human disease, and develop a new class of therapeutics.
Areas of Research Interest and Expertise: Chromatin & Gene Regulation, Protein Biochemistry, Cancer Biology, Human Disease, Therapeutics
Previous Positions:
Assistant Professor, Dana-Farber Cancer Institute & Harvard Medical School PhD, Stanford University School of Medicine (Advisor: Gerald Crabtree) BA, University of California, Berkeley
Research Summary:
Genome sequencing studies revealed that genes encoding understudied macromolecular machines, called ATP-dependent chromatin remodelers, are extensively mutated and serve as key cellular vulnerabilities in human cancer. In a series of groundbreaking studies, Cigall Kadoch, PhD and her team deciphered how these large complexes regulate DNA accessibility and gene expression. The Kadoch Lab also unraveled how disease-causing mutations impact their structure and function in an expanding list of diseases, that includes cancer, neurodevelopmental disorders and immunodeficiencies. Dr. Kadoch has built upon these discoveries to develop novel therapeutics, which are being tested in clinical trials and could revolutionize the treatment of diverse maladies.
“The architecture of our ‘code for life’, or DNA, is central to proper gene expression and function of every living cell and tissue. Disruptions in genomic topology frequently drive human disease, motivating our quest to define detailed mechanisms and develop viable therapeutic opportunities.”
2023 Paul Marks Prize for Cancer Research, Memorial Sloan Kettering Cancer Center 2023 & 2020 Finalist, Blavatnik National Awards, Blavatnik Family Foundation and NYAS 2022 FASEB Excellence in Science Award, Federation of American Societies for Experimental Biology (FASEB) 2022 Howard Hughes Medical Institute (HHMI) Investigator, HHMI 2020 American Association for Cancer Research (AACR) Outstanding Achievement in Basic Cancer Research Award, AACR 2019 American Society for Cell Biology (ASCB) Early Career Life Scientist Award 2019 AAAS Martin and Rose Wachtel Cancer Research Prize, American Academy for the Advancement of Science 2016 Popular Science Brilliant 10, Popular Science 2015 MIT Technology Review Innovators Under 35, MIT Technology Review 2014 Forbes 30 Under 30 in Science and Healthcare, Forbes